We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+19.61%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.63B
AUM Growth
+$411M
Cap. Flow
+$161M
Cap. Flow %
6.13%
Top 10 Hldgs %
44.92%
Holding
2,471
New
804
Increased
452
Reduced
440
Closed
595

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$13.4M
2
BOLD
Audentes Therapeutics, Inc
BOLD
+$10.5M
3
CISN
Cision Ltd. Ordinary Share
CISN
+$10M
4
MDCO
Medicines Co
MDCO
+$8.78M
5
TIF
Tiffany & Co.
TIF
+$7.91M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$42.5M
2
VSM
Versum Materials, Inc.
VSM
+$29.7M
3
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$23.3M
4
AABA
Altaba Inc
AABA
+$18.8M
5
CPE
Callon Petroleum Company
CPE
+$17.2M

Sector Composition

Rank Sector Weight
1 Technology 4.59%
2 Healthcare 3.78%
3 Consumer Discretionary 3.06%
4 Communication Services 2.48%
5 Real Estate 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACMR icon
1726
ACM Research
ACMR
$5.79B
$7K ﹤0.01%
+1,200
New +$5.9K
HRTX icon
1727
Heron Therapeutics
HRTX
$92.9M
$7K ﹤0.01%
+294
New +$6.5K
MYRG icon
1728
MYR Group
MYRG
$5.25B
$7K ﹤0.01%
200
-600
-75% -$19.8K
PETS icon
1729
PetMed Express
PETS
$42.3M
$7K ﹤0.01%
+278
New +$6.23K
RPAY icon
1730
Repay Holdings
RPAY
$327M
$7K ﹤0.01%
+500
New +$6.98K
STWD icon
1731
Starwood Property Trust
STWD
$6.09B
$7K ﹤0.01%
284
-5,316
-95% -$130K
TRUP icon
1732
PUT
Trupanion
TRUP
$1.18B
$7K ﹤0.01%
+200
New +$5.88K
GRTX
1733
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$7K ﹤0.01%
+558
New +$6.8K
CLVS
1734
DELISTED
Clovis Oncology, Inc.
CLVS
$7K ﹤0.01%
626
-76
-11% -$553
XENT
1735
DELISTED
Intersect ENT, Inc
XENT
$7K ﹤0.01%
279
+9
+3% +$182
AEGN
1736
DELISTED
Aegion Corp
AEGN
$7K ﹤0.01%
+300
New +$6.49K
CHK
1737
CALL
DELISTED
Chesapeake Energy Corporation
CHK
$7K ﹤0.01%
45
+6
+15% +$1.21K
AES icon
1738
AES
AES
$10.5B
$6K ﹤0.01%
+320
New +$5.73K
AMPY icon
1739
Amplify Energy
AMPY
$166M
$6K ﹤0.01%
+974
New +$6.27K
AMRN
1740
PUT
Amarin Corp
AMRN
$303M
$6K ﹤0.01%
+15
New +$5.7K
APLS
1741
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$6K ﹤0.01%
+200
New +$5.54K
ARDX icon
1742
Ardelyx
ARDX
$997M
$6K ﹤0.01%
+800
New +$4.86K
AUTL
1743
Autolus Therapeutics
AUTL
$562M
$6K ﹤0.01%
460
-80
-15% -$1.05K
BHE icon
1744
Benchmark Electronics
BHE
$2.96B
$6K ﹤0.01%
+166
New +$5.48K
CATY icon
1745
Cathay General Bancorp
CATY
$4.24B
$6K ﹤0.01%
145
-4,355
-97% -$159K
EZPW icon
1746
Ezcorp Inc
EZPW
$1.71B
$6K ﹤0.01%
+907
New +$5.21K
GME icon
1747
GameStop
GME
$8.6B
$6K ﹤0.01%
3,620
-186,020
-98% -$273K
GPC icon
1748
Genuine Parts
GPC
$18.7B
$6K ﹤0.01%
+54
New +$5.55K
TPST icon
1749
Tempest Therapeutics
TPST
$14.6M
$6K ﹤0.01%
+5
New +$7.05K
ULH icon
1750
Universal Logistics Holdings
ULH
$529M
$6K ﹤0.01%
302
-3,271
-92% -$68.2K
68 69
70
71 72

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Prelude Capital Management held 2,471 positions worth $2.63B, up 19% from $2.22B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prelude Capital Management deployed $161M of net new capital in Q4 2019, opening 804 new positions and adding to 452 existing holdings. Its largest new stake was Netflix: 452,870 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 4.6% of assets, down from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Callon Petroleum Company, an estimated $17.2M trimmed.

  • Prelude Capital Management's largest Q4 2019 buy was Netflix: 452,870 shares worth $14.7M.
  • Prelude Capital Management added most to Cision Ltd. Ordinary Share in Q4 2019, an estimated $10M increase.
  • Prelude Capital Management's biggest Q4 2019 reduction was Callon Petroleum Company, cutting an estimated $17.2M.
  • Prelude Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $42.5M.
  • Prelude Capital Management's ten largest holdings make up 45% of its $2.63B portfolio in Q4 2019.
  • Prelude Capital Management opened 804 new positions and closed 595 in Q4 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $2.63B.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.